Super Obese Female AVR (EP Video)
Jesse Lobodinsky presents a case report on a super obese patient undergoing an aortic valve replacement (28:45 minutes).
Bridge to Cardiac Transplant: 2 Case Studies (EP Video)
Marty Sinkewich presents two case reports on bridge to transplant patients from the Cleveland Clinic (25:20 minutes).
Collapsed Cardioplegia Line (EP Video)
Jessica Lance presents a case report where a collapsed cardioplegia line became a major issue (16:11 minutes).
TAVR: Patient Selection and Imaging (EP Video)
Dr. Arvind Kapila discusses patient selection and imaging in TAVR procedures (30:33 minutes).
Normothermic Ex-Vivo Lung Perfusion (EP Video)
Erica Powell presents a case report on ex-vivo lung perfusion (10:46 minutes).
Emergent Salvage Pediatric Thrombus Removal (EP Video)
Allan Phang presents a case report on the emergent removal of a thrombus in a pediatric patient (33:11 minutes).
The 876 Hour ECMO Battle (EP Video)
Dee Ann Griffin presents a case report on a patient on ECMO for an 876 hour period (18:14 minutes).
Sorin Perceval Valve (EP Video)
Autumn Gibbs presents a case report involving the Sorin Perceval suturless aortic valve (14:08 minutes).
Super Obese Female AVR (EP Video)
Jesse Lobodinsky presents a case report on a super obese patient undergoing an aortic valve replacement (28:45 minutes).
Collapsed Cardioplegia Line (EP Video)
Jessica Lance presents a case report where a collapsed cardioplegia line became a major issue (16:11 minutes).
Achilles Tendinopathy Management: A Pilot Randomized Controlled Trial Comparing Platelet-Rich Plasma Injection with an Eccentric Loading Programme
We conducted a pilot randomized controlled trial to evaluate the feasibility of conducting a larger trial to evaluate the difference in Victorian Institute of Sports Assessment-Achilles (VISA-A) scores at six months between patients with Achilles tendinopathy treated with a platelet-rich plasma (PRP) injection compared with an eccentric loading programme.
Does Tranexamic Acid Stop Haemoptysis
Current best evidence indicates that tranexamic acid may reduce both the duration and volume of bleeding, with low risk of short-term thromboembolic complications, in patients with haemoptysis.